Contact Us
|
Client Login
PRODUCTS & SERVICES
Antibody Products
Antibody Products Store
Neuroscience
Epitope Tags
Structural Proteins & Cell Components
Signal Transduction
Immunopathology
Detection Chemistries & Ancillaries
Custom Immunology Services
Clinical Services
Bioanalytical
Central Laboratory
Clinical Development (Phase I-III)
Discovery & Translational Services
Antibody Products
Biomarker Center of Excellence
BioPathways
Computational Biology
Discovery
Genomics Laboratory
Immunology
Vaccines & Infectious Disease
Nonclinical Services
Antibody Products
Bioanalytical Services
Discovery
Drug Metabolism & Pharmacokinetics
Immunology
Radiosynthesis
Research Models
Safety Pharmacology
Toxicology
Vaccines & Infectious Disease
Biopharmaceutical CMC Solutions
Biorepository Services
Environmental Sciences
Genomics Laboratory
Integration in Drug Development
Market Access
Nutritional Chemistry & Food Safety
Secure Data Access
Strategic Partnering
CAREERS
Search Jobs
College / University
Featured Jobs
Diversity
Benefits
现在就加入科文斯
STUDY PARTICIPANTS
INVESTORS
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
NEWS
Press Releases
Media Relations
ABOUT COVANCE
Company Overview
Global Locations
Corporate Responsibility
Business Integrity Program
Animal Welfare
Covance.Asia
RESOURCE CENTER
Blog
Investors
Investor Information
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
Home
> Investors >
Financial Information
>
SEC Filings Form
Financial Information
SEC Filings Form
Form 4
COVANCE INC filed this Form 4 on 07/03/12
Entire Document (4.2 KB)
4 - PRIMARY DOCUMENT
Home
|
Animal Welfare
|
Privacy Policy
|
Contact Us
|
Site Map
|
Investigators
|
Covance.Asia
RSS
© Copyright 2013 Covance Inc. All rights reserved.